FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

79605009: 3 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    132068015 Three en Synonym Active Entire term case insensitive SNOMED CT core module
    3442100016 3 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442101017 3 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    3 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    3 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 2
    Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 2
    Product containing precisely potassium chloride 3 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 4.5 milligram/1 milliliter conventional release solution for infusion (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 2 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely flupentixol (as flupentixol hydrochloride) 3 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing only naphazoline and polyvinyl alcohol and zinc sulfate (medicinal product) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only chlorphenamine and methscopolamine and pseudoephedrine (medicinal product) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only chlorphenamine and phenylephrine and phenyltoloxamine (medicinal product) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only chlorphenamine and phenylephrine and phenyltoloxamine in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only cetyl alcohol and colfosceril and tyloxapol (medicinal product) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only chlorphenamine and paracetamol and phenylephrine (medicinal product) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 30 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only aliskiren and amlodipine and hydrochlorothiazide in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely tobramycin 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing only amlodipine and hydrochlorothiazide and olmesartan in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely pramipexole dihydrochloride 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 25 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely gentamicin sulfate 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing only amlodipine and hydrochlorothiazide and valsartan in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 gram conventional release eye ointment (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely tobramycin 3 milligram/1 gram conventional release eye ointment (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing only caffeine and isometheptene and paracetamol in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely hydromorphone hydrochloride 3 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely dexamethasone 500 microgram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 2
    Product containing only magnesium hydroxide and omeprazole and sodium bicarbonate in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely magnesium hydroxide 700 milligram and omeprazole 20 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely paliperidone 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely glyceryl trinitrate 3 milligram/1 each prolonged-release buccal tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely adapalene 3 milligram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter and hydroquinone 40 milligram/1 milliliter and tretinoin 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release ear solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely ethinylestradiol 20 microgram and ferrous fumarate 75 milligram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 3
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely dextromethorphan hydrobromide 3 milligram/1 milliliter and promethazine hydrochloride 1.25 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 2
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and guaifenesin 40 milligram/1 milliliter and hydrocodone bitartrate 1 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 3
    Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely brompheniramine 800 microgram/1 milliliter and dextromethorphan 3 milligram/1 milliliter and pseudoephedrine 12 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and codeine phosphate 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely brompheniramine 800 microgram/1 milliliter and dextromethorphan 6 milligram/1 milliliter and pseudoephedrine 12 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and pseudoephedrine hydrochloride 6 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 2 milligram/1 milliliter and phenylephrine hydrochloride 1 milligram/1 milliliter and promethazine hydrochloride 1.25 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Existential restriction modifier
    Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Existential restriction modifier 1

    Start Previous Page 4 of 6 Next End

    This concept is not in any reference sets

    Back to Start